OBJECTIVE: The objective of this study was to measure agreement between three treatment decisional capacity assessment instruments in mild to moderate dementia. METHOD: Subjects (N=79) were recruited from the community. Rating agreement was evaluated with kappa statistics. RESULTS: Three-way agreement was fair for overall capacity (kappa=0.451), very good for understanding (0.618), very poor for choice (0.158), and no better than chance for reasoning and appreciation. Pairwise agreement showed a similar pattern. CONCLUSIONS: With the exception of understanding, current treatment decisional capacity assessment instruments do not consistently agree with one another in assessing treatment decision abilities.
OBJECTIVE: The objective of this study was to measure agreement between three treatment decisional capacity assessment instruments in mild to moderate dementia. METHOD: Subjects (N=79) were recruited from the community. Rating agreement was evaluated with kappa statistics. RESULTS: Three-way agreement was fair for overall capacity (kappa=0.451), very good for understanding (0.618), very poor for choice (0.158), and no better than chance for reasoning and appreciation. Pairwise agreement showed a similar pattern. CONCLUSIONS: With the exception of understanding, current treatment decisional capacity assessment instruments do not consistently agree with one another in assessing treatment decision abilities.
Authors: Andrea Pace; Johan A F Koekkoek; Martin J van den Bent; Helen J Bulbeck; Jane Fleming; Robin Grant; Heidrun Golla; Roger Henriksson; Simon Kerrigan; Christine Marosi; Ingela Oberg; Stefan Oberndorfer; Kathy Oliver; H Roeline W Pasman; Emilie Le Rhun; Alasdair G Rooney; Roberta Rudà; Simone Veronese; Tobias Walbert; Michael Weller; Wolfgang Wick; Martin J B Taphoorn; Linda Dirven Journal: Neurooncol Pract Date: 2020-07-16